We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Veracyte
VCYT
$3.73B
| $946K | ﹤0.01% |
17,605
+259
| +1% | +$14.9K |
|
1577
Keurig Dr Pepper
KDP
$39.7B
| $941K | ﹤0.01% |
27,385
-256
| -0.9% | -$8.3K |
|
1578
Tandem Diabetes Care
TNDM
$1.63B
| $937K | ﹤0.01% |
10,826
-211
| -2% | -$19.6K |
|
1579
Vornado Realty Trust
VNO
$7.24B
| $937K | ﹤0.01% |
20,640
+13,400
| +185% | +$555K |
|
1580
Ameresco
AMRC
$1.37B
| $936K | ﹤0.01% |
19,256
+704
| +4% | +$38.8K |
|
1581
Park Hotels & Resorts
PK
$2.89B
| $935K | ﹤0.01% |
43,319
+14,119
| +48% | +$280K |
|
1582
Sabesp
SBS
$17.7B
| $935K | ﹤0.01% |
657,586
+305,916
| +87% | +$440K |
|
1583
Jones Lang LaSalle
JLL
$16.7B
| $933K | ﹤0.01% |
+5,225
| New | +$852K |
|
|
MIK
1584
DELISTED
Michaels Stores, Inc
MIK
| $933K | ﹤0.01% |
42,510
-50,254
| -54% | -$888K |
|
1585
PC Connection
CNXN
$2.04B
| $932K | ﹤0.01% |
20,086
-14,372
| -42% | -$710K |
|
|
LOVE
1586
LoveSac
LOVE
$258M
| $932K | ﹤0.01% |
16,473
+8,329
| +102% | +$460K |
|
1587
Newmark Group
NMRK
$2.62B
| $931K | ﹤0.01% |
+93,082
| New | +$834K |
|
1588
Unisys
UIS
$205M
| $930K | ﹤0.01% |
36,574
+7,596
| +26% | +$188K |
|
1589
Celsius Holdings
CELH
$7.11B
| $923K | ﹤0.01% |
57,624
-43,830
| -43% | -$823K |
|
|
FLNT
1590
Fluent
FLNT
$130M
| $922K | ﹤0.01% |
+37,481
| New | +$1.3M |
|
|
NEWR
1591
DELISTED
New Relic, Inc.
NEWR
| $918K | ﹤0.01% |
15,055
-73,437
| -83% | -$4.88M |
|
|
PMT
1592
PennyMac Mortgage Investment
PMT
$824M
| $912K | ﹤0.01% |
46,533
| – | – |
|
1593
Victory Capital Holdings
VCTR
$6.99B
| $912K | ﹤0.01% |
35,687
+509
| +1% | +$12.5K |
|
1594
Sociedad Química y Minera de Chile
SQM
$20.6B
| $910K | ﹤0.01% |
17,155
+1,362
| +9% | +$74.6K |
|
|
AYX
1595
DELISTED
Alteryx Inc
AYX
| $908K | ﹤0.01% |
11,180
+5,612
| +101% | +$595K |
|
1596
Cimpress
CMPR
$2.32B
| $901K | ﹤0.01% |
8,998
-3,850
| -30% | -$379K |
|
1597
Kulicke & Soffa
KLIC
$4.76B
| $901K | ﹤0.01% |
18,356
+1,525
| +9% | +$66.2K |
|
1598
Standard BioTools
LAB
$309M
| $896K | ﹤0.01% |
198,147
-121,031
| -38% | -$665K |
|
|
ORBC
1599
DELISTED
ORBCOMM, Inc.
ORBC
| $896K | ﹤0.01% |
117,466
+83,522
| +246% | +$658K |
|
1600
Aaon
AAON
$7.07B
| $895K | ﹤0.01% |
19,187
+876
| +5% | +$43K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.